FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Gunnar Kristensen

Research Profile

Disorders

Concepts & Ideas

Procedures

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Lars O Baumbusch; Kathryn Alsop; David D L Bowtell; Pat Brown; Anna deFazio; Dariush Etemadmoghadam; Sian Fereday; Ruth Holm; Gunnar Kristensen; Knut Liestøl; Ole Christian Lingjaerde; Gillian Mitchell; Marci E Schaner; Yun Wang; Aslaug Helland; Anne-Lise Børresen-Dale
High levels of genomic aberrations in serous ovarian cancers are associated with better survival.
K Lindemann; A B Lopez; M Ridderheim; G Stuart; Ignace Vergote; E Vrdoljak; E Aavall-Lundquvist; R D Christensen; E Eisenhauer; J Green; H Havsteen; H Hirte; M A Izquierdo; J Kærn; Gunnar Kristensen
First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)--a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTG.
Claes G Tropé; Vera M Abeler; Gunnar Kristensen
Diagnosis and treatment of sarcoma of the uterus. A review.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Gunnar Kristensen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Lars O Baumbusch; Kathryn Alsop; David D L Bowtell; Pat Brown; Anna deFazio; Dariush Etemadmoghadam; Sian Fereday; Ruth Holm; Gunnar Kristensen; Knut Liestøl; Ole Christian Lingjaerde; Gillian Mitchell; Marci E Schaner; Yun Wang; Aslaug Helland; Anne-Lise Børresen-Dale
High levels of genomic aberrations in serous ovarian cancers are associated with better survival.
PloS one 2013;8(1):e54356.
2012: K Lindemann; A B Lopez; M Ridderheim; G Stuart; Ignace Vergote; E Vrdoljak; E Aavall-Lundquvist; R D Christensen; E Eisenhauer; J Green; H Havsteen; H Hirte; M A Izquierdo; J Kærn; Gunnar Kristensen
First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)--a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTG.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(10):2613-9.
2012: Claes G Tropé; Vera M Abeler; Gunnar Kristensen
Diagnosis and treatment of sarcoma of the uterus. A review.
Acta oncologica (Stockholm, Sweden) 2012;51(6):694-705.
2011: Cathinka Halle; Marit Holden; Ruth Holm; Gunnar Kristensen; Malin Lando; Kolbein Sundfør; Debbie H Svendsrud; Trevor Clancy; Heidi Lyng
Membranous expression of ectodomain isoforms of the epidermal growth factor receptor predicts outcome after chemoradiotherapy of lymph node-negative cervical cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(16):5501-12.
2011: Erlend K F Andersen; Gunnar Kristensen; Heidi Lyng; Eirik Malinen
Pharmacokinetic analysis and k-means clustering of DCEMR images for radiotherapy outcome prediction of advanced cervical cancers.
Acta oncologica (Stockholm, Sweden) 2011;50(6):859-65.
2011: Ingvild Vistad; Milada Cvancarova; Gunnar Kristensen; Sophie Dorothea Fosså
A study of chronic pelvic pain after radiotherapy in survivors of locally advanced cervical cancer.
Journal of cancer survivorship : research and practice 2011;5(2):208-16.
2011: Tate Thigpen; Monica Bacon; Jonathan Berek; Nicoletta Colombo; Philip DiSaia; Andreas duBois; Gilles Freyer; Keiichi Fujiwara; Dolores Gallardo; William Hoskins; Henry Kitchener; Gunnar Kristensen; Robert Mannel; Maurie Markman; Jessica McAlpine; Jacobus Pfisterer; Marie Plante; Andres Poveda; Michael Quinn; Nick Reed; Lawrence Rubinstein; Gavin C E Stuart; Ann Marie Swart
First-line therapy in ovarian cancer trials.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2011;21(4):756-62.
2011: Gordon John Sampson Rustin; Ignace Vergote; Elizabeth Eisenhauer; Eric Pujade-Lauraine; Michael Quinn; Tate Thigpen; Andreas du Bois; Gunnar Kristensen; Anders Jakobsen; Satoru Sagae; Kathryn Greven; M Parmar; Michael Friedlander; Andres Cervantes; Jan Vermorken
Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG).
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2011;21(2):419-23.
2011: Åslaug Helland; Michael S Anglesio; Joshy George; Prue A Cowin; Cameron N Johnstone; Colin M House; Karen E Sheppard; Dariush Etemadmoghadam; Nataliya Melnyk; Anil K Rustgi; Wayne A Phillips; Hilde Johnsen; Ruth Holm; Gunnar Kristensen; Michael J Birrer; Richard B Pearson; Anne-Lise Børresen-Dale; David G Huntsman; Anna deFazio; Chad J Creighton; Gordon K Smyth; David D L Bowtell
Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancers.
PloS one 2011;6(4):e18064.
2011: Leen Verleye; Petronella B Ottevanger; Gunnar Kristensen; Tom Ehlen; Nick Johnson; Maria E L van der Burg; Nick S Reed; René H M Verheijen; Katja N Gaarenstroom; Berit Mosgaard; Jose M Seoane; Jacobus van der Velden; Robert Lotocki; Winette van der Graaf; Björn Penninckx; Corneel Coens; Gavin Stuart; Ignace Vergote
Quality of pathology reports for advanced ovarian cancer: are we missing essential information? An audit of 479 pathology reports from the EORTC-GCG 55971/NCIC-CTG OV13 neoadjuvant trial.
European journal of cancer (Oxford, England : 1990) 2011;47(1):57-64.
2010: Gordon J S Rustin; Maria E L van der Burg; Clare L Griffin; David Guthrie; Alan Lamont; Gordon C Jayson; Gunnar Kristensen; César Mediola; Corneel Coens; Wendi Qian; Mahesh K B Parmar; Ann Marie Swart
Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial.
Lancet 2010;376(9747):1155-63.
2010: Andreas du Bois; Jørn Herrstedt; Anne-Claire Hardy-Bessard; Hans-Helge Müller; Philipp Harter; Gunnar Kristensen; Florence Joly; Jens Huober; Elisabeth Avall-Lundqvist; Béatrice Weber; Christian Kurzeder; Svetislav Jelic; Eric Pujade-Lauraine; Alexander Burges; Jacobus Pfisterer; Martina Gropp; Anne Staehle; Pauline Wimberger; Christian Jackisch; Jalid Sehouli
Phase III trial of carboplatin plus paclitaxel with or without gemcitabine in first-line treatment of epithelial ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(27):4162-9.
2010: Ignace Vergote; Claes G Tropé; Frédéric Amant; Gunnar Kristensen; Tom Ehlen; Nick Johnson; René H M Verheijen; Maria E L van der Burg; Angel J Lacave; Pierluigi Benedetti Panici; Gemma G Kenter; Antonio Casado; Cesar Mendiola; Corneel Coens; Leen Verleye; Gavin C E Stuart; Sergio Pecorelli; Nick S Reed
Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer.
The New England journal of medicine 2010;363(10):943-53.
2010: Thomas Hogberg; Mauro Signorelli; Carlos Freire de Oliveira; Roldano Fossati; Andrea Alberto Lissoni; Bengt Sorbe; Håkan Andersson; Seija Grenman; Caroline Lundgren; Per Rosenberg; Karin Boman; Bengt Tholander; Giovanni Scambia; Nicholas Reed; Gennaro Cormio; Germana Tognon; Jackie Clarke; Tomasz Sawicki; Paolo Zola; Gunnar Kristensen
Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer--results from two randomised studies.
European journal of cancer (Oxford, England : 1990) 2010;46(13):2422-31.
2010: Eric Pujade-Lauraine; Uwe Wagner; Elisabeth Aavall-Lundqvist; Val Gebski; Mark Heywood; Paul A Vasey; Birgit Volgger; Ignace Vergote; Sandro Pignata; Annamaria Ferrero; Jalid Sehouli; Alain Lortholary; Gunnar Kristensen; Christian Jackisch; Florence Joly; Chris Brown; Nathalie Le Fur; Andreas du Bois
Pegylated liposomal Doxorubicin and Carboplatin compared with Paclitaxel and Carboplatin for patients with platinum-sensitive ovarian cancer in late relapse.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(20):3323-9.
2010: Ignace Vergote; Eric Pujade-Lauraine; Sandro Pignata; Gunnar Kristensen; Jonathan Ledermann; Antonio Casado; Jalid Sehouli; Mansoor Raza Mirza; Roldano Fossati; Christian Marth; Carine Creutzberg; Jose Del Campo; Nadeem Siddiqui; Paula Calvert; Aris Bamias; Gokhan Tulunay; Ate G J van der Zee; Andreas du Bois
European Network of Gynaecological Oncological Trial Groups' requirements for trials between academic groups and pharmaceutical companies.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2010;20(3):476-8.
2010: Taran Paulsen Hellebust; Gunnar Kristensen; Dag Rune Olsen
Late effects after radiotherapy for locally advanced cervical cancer: comparison of two brachytherapy schedules and effect of dose delivered weekly.
International journal of radiation oncology, biology, physics 2010;76(3):713-8.
2009: A Kongsgaard Rud; S Bjørgo; Gunnar Kristensen; Ulf E Kongsgaard
Hyperbaric oxygen therapy for late radiation tissue injury in gynaecological patients.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2009;17(12):1517-21.
2009: Malin Lando; Marit Holden; Linn C Bergersen; Debbie H Svendsrud; Trond Stokke; Kolbein Sundfør; Ingrid K Glad; Gunnar Kristensen; Heidi Lyng
Gene dosage, expression, and ontology analysis identifies driver genes in the carcinogenesis and chemoradioresistance of cervical cancer.
PLoS genetics 2009;5(11):e1000719.
2009: Wanja Kildal; Manohar Pradhan; Vera M Abeler; Gunnar Kristensen; Håvard E Danielsen
Beta-catenin expression in uterine sarcomas and its relation to clinicopathological parameters.
European journal of cancer (Oxford, England : 1990) 2009;45(13):2412-7.
2009: Ruth Holm; Tayeba Ali; Debbie H Svendsrud; Jahn M Nesland; Gunnar Kristensen; Heidi Lyng
Expression of 14-3-3sigma in cervical squamous cell carcinomas: relationship with clinical outcome.
Oncology reports 2009;22(1):11-5.
2009: W Kildal; V M Abeler; Gunnar Kristensen; M Jenstad; S Ø Thoresen; H E Danielsen
The prognostic value of DNA ploidy in a total population of uterine sarcomas.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(6):1037-41.
2009: Ingvild Vistad; Gunnar Kristensen; Sophie D Fosså; Alv A Dahl; Lars Mørkrid
Intestinal malabsorption in long-term survivors of cervical cancer treated with radiotherapy.
International journal of radiation oncology, biology, physics 2009;73(4):1141-7.
2009: Vera M Abeler; Odd Røyne; Steinar Thoresen; Håvard E Danielsen; Jahn M Nesland; Gunnar Kristensen
Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients.
Histopathology 2009;54(3):355-64.
2009: Mandi Murph; Wenbin Liu; Shuangxing Yu; Yiling Lu; Hassan Hall; Bryan T. J. Hennessy; John Lahad; Marci Schaner; Aslaug Helland; Gunnar Kristensen; Anne-Lise Børresen-Dale; Gordon B Mills
Lysophosphatidic acid-induced transcriptional profile represents serous epithelial ovarian carcinoma and worsened prognosis.
PloS one 2009;4(5):e5583.
2008: Ingvild Vistad; Milada Cvancarova; Sophie Dorothea Fosså; Gunnar Kristensen
Postradiotherapy morbidity in long-term survivors after locally advanced cervical cancer: how well do physicians' assessments agree with those of their patients?
International journal of radiation oncology, biology, physics 2008;71(5):1335-42.
2008: A Kathrine Lie; Gunnar Kristensen
Human papillomavirus E6/E7 mRNA testing as a predictive marker for cervical carcinoma.
Expert review of molecular diagnostics 2008;8(4):405-15.
2008: Ruth Holm; Irene Kraus; Hanne Skomedal; Anita Langerød; Gunnar Kristensen; Heidi Lyng
Human papillomavirus DNA and e6/e7 mRNA status in relation to survival of patients treated for cervical squamous cell carcinoma.
The open virology journal 2008;2():74-81.
2008: Ruth Holm; Gregg Van de Putte; Zhenhe Suo; A Kathrine Lie; Gunnar Kristensen
Expressions of EphA2 and EphrinA-1 in early squamous cell cervical carcinomas and their relation to prognosis.
International journal of medical sciences 2008;5(3):121-6.
2008: Heidi Lyng; Malin Lando; Runar S Brøvig; Debbie H Svendsrud; Morten Johansen; Eivind Galteland; Odd T Brustugun; Leonardo A. Meza-Zepeda; Ola Myklebost; Gunnar Kristensen; Eivind Hovig; Trond Stokke
GeneCount: genome-wide calculation of absolute tumor DNA copy numbers from array comparative genomic hybridization data.
Genome biology 2008;9(5):R86.
2007: Ingvild Vistad; Sophie D Fosså; Gunnar Kristensen; Alv A Dahl
Chronic fatigue and its correlates in long-term survivors of cervical cancer treated with radiotherapy.
BJOG : an international journal of obstetrics and gynaecology 2007;114(9):1150-8.
2007: Edward L Trimble; J Davis; P Disaia; K Fujiwara; D Gaffney; Gunnar Kristensen; J Ledermann; J Pfisterer; M Quinn; N Reed; Mason Schoenfeldt; J T Thigpen
Clinical trials in gynecological cancer.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2007;17(3):547-56.
2007: Y Wang; Gunnar Kristensen; A-L Børresen-Dale; Aslaug Helland
TP53 mutations and codon 72 genotype--impact on survival among ovarian cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(5):964-6.
2007: Ingvild Vistad; Sophie D Fosså; Gunnar Kristensen; Arnstein Mykletun; Alv A Dahl
The sexual activity questionnaire: pychometric properties and normative data in a norwegian population sample.
Journal of women's health (2002) 2007;16(1):139-48.
2007: Heidi Lyng; Beathe Sitter; Tone F Bathen; Line R Jensen; Kolbein Sundfør; Gunnar Kristensen; Ingrid S Gribbestad
Metabolic mapping by use of high-resolution magic angle spinning 1H MR spectroscopy for assessment of apoptosis in cervical carcinomas.
BMC cancer 2007;7():11.
2006: Qinghua Wu; Zhenhe Suo; Gunnar Kristensen; Mark Baekelandt; Jahn M Nesland
The prognostic impact of EphB2/B4 expression on patients with advanced ovarian carcinoma.
Gynecologic oncology 2006;102(1):15-21.
2006: Irene Kraus; Tor Molden; Ruth Holm; A Kathrine Lie; Frank Karlsen; Gunnar Kristensen; Hanne Skomedal
Presence of E6 and E7 mRNA from human papillomavirus types 16, 18, 31, 33, and 45 in the majority of cervical carcinomas.
Journal of clinical microbiology 2006;44(4):1310-7.
2006: Jen-Tsan Chi; Zhen Wang; Dimitry S A Nuyten; Edwin H Rodriguez; Marci E Schaner; Ali Salim; Yun Wang; Gunnar Kristensen; Aslaug Helland; Anne-Lise Børresen-Dale; Amato J Giaccia; Michael T Longaker; Trevor Hastie; George P Yang; Marc J van de Vijver; Patrick O Brown
Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers.
PLoS medicine 2006;3(3):e47.
2006: Ben Davidson; Virginia Espina; Seth M Steinberg; Vivi Ann Flørenes; Lance A Liotta; Gunnar Kristensen; Claes G Tropé; Aasmund Berner; Elise C Kohn
Proteomic analysis of malignant ovarian cancer effusions as a tool for biologic and prognostic profiling.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(3 Pt 1):791-9.
2006: Heidi Lyng; Runar S Brøvig; Debbie H Svendsrud; Ruth Holm; Olav Kaalhus; Kjetil Knutstad; Halldis Oksefjell; Kolbein Sundfør; Gunnar Kristensen; Trond Stokke
Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer.
BMC genomics 2006;7():268.
2006: Anders Andersen; David J Warren; Paal F Brunsvig; Steinar Aamdal; Gunnar Kristensen; Harald Olsen
High sensitivity assays for docetaxel and paclitaxel in plasma using solid-phase extraction and high-performance liquid chromatography with UV detection.
BMC clinical pharmacology 2006;6():2.
2005: Liping Han; Ziming Dong; Yuhuan Qiao; Gunnar Kristensen; Ruth Holm; Jahn M Nesland; Zhenhe Suo
The clinical significance of EphA2 and Ephrin A-1 in epithelial ovarian carcinomas.
Gynecologic oncology 2005;99(2):278-86.
2005: Gregg van de Putte; A Kathrine Lie; Werner Vach; Mark Baekelandt; Gunnar Kristensen
Risk grouping in stage IB squamous cell cervical carcinoma.
Gynecologic oncology 2005;99(1):106-12.
2005: Yun Wang; Gunnar Kristensen; Aslaug Helland; Jahn M Nesland; Anne-Lise Børresen-Dale; Ruth Holm
Protein expression and prognostic value of genes in the erb-b signaling pathway in advanced ovarian carcinomas.
American journal of clinical pathology 2005;124(3):392-401.
2005: Gregg van de Putte; Ruth Holm; A Kathrine Lie; Mark Baekelandt; Gunnar Kristensen
Markers of apoptosis in stage IB squamous cervical carcinoma.
Journal of clinical pathology 2005;58(6):590-4.
2005: Ellen V Stevens; Mark Raffeld; Virginia Espina; Gunnar Kristensen; Claes G Trope'; Elise C Kohn; Ben Davidson
Expression of xeroderma pigmentosum A protein predicts improved outcome in metastatic ovarian carcinoma.
Cancer 2005;103(11):2313-9.
2005: Wanja Kildal; Björn Risberg; Vera M Abeler; Gunnar Kristensen; Jon Sudbø; Jahn M Nesland; Håvard E Danielsen
beta-catenin expression, DNA ploidy and clinicopathological features in ovarian cancer: a study in 253 patients.
European journal of cancer (Oxford, England : 1990) 2005;41(8):1127-34.
2005: Yun Wang; Aslaug Helland; Ruth Holm; Gunnar Kristensen; Anne-Lise Børresen-Dale
PIK3CA mutations in advanced ovarian carcinomas.
Human mutation 2005;25(3):322.
2005: Magdalena Benetkiewicz; Yun Wang; Marci Schaner; Pei Wang; Kiran K Mantripragada; Patrick Buckley; Gunnar Kristensen; Anne-Lise Børresen-Dale; Jan P Dumanski
High-resolution gene copy number and expression profiling of human chromosome 22 in ovarian carcinomas.
Genes, chromosomes & cancer 2005;42(3):228-37.
2005: A du Bois; M Quinn; T Thigpen; J Vermorken; E Avall-Lundqvist; M Bookman; D Bowtell; M Brady; A Casado; A Cervantes; E Eisenhauer; M Friedlaender; K Fujiwara; S Grenman; J P Guastalla; P Harper; T Hogberg; S Kaye; Henry C Kitchener; Gunnar Kristensen; R Mannel; W Meier; B Miller; J P Neijt; Amit Oza; R Ozols; M Parmar; S Pecorelli; J Pfisterer; A Poveda; D Provencher; E Pujade-Lauraine; M Randall; J Rochon; G Rustin; S Sagae; F Stehman; G Stuart; E Trimble; P Vasey; I Vergote; R Verheijen; U Wagner
2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16 Suppl 8():viii7-viii12.
2005: G Stuart; E Avall-Lundqvist; A du Bois; M Bookman; D Bowtell; M Brady; A Casado; A Cervantes; E Eisenhauer; M Friedlaender; K Fujiwara; S Grenman; J P Guastalla; P Harper; T Hogberg; S Kaye; Henry C Kitchener; Gunnar Kristensen; R Mannel; W Meier; B Miller; Amit Oza; R Ozols; M Parmar; J Pfisterer; A Poveda; D Provencher; E Pujade-Lauraine; M Quinn; M Randall; J Rochon; G Rustin; S Sagae; F Stehman; E Trimble; T Thigpen; P Vasey; I Vergote; R Verheijen; J Vermorken; U Wagner
3rd International Ovarian Cancer Consensus Conference: outstanding issues for future consideration.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16 Suppl 8():viii36-viii38.
2005: Tate Thigpen; G Stuart; Andreas du Bois; M Friedlander; K Fujiwara; J P Guastalla; S Kaye; Henry C Kitchener; Gunnar Kristensen; R Mannel; W Meier; B Miller; Andres Poveda; D Provencher; F Stehman; Ignace Vergote
Clinical trials in ovarian carcinoma: requirements for standard approaches and regimens.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16 Suppl 8():viii13-viii19.
2005: Pedro Kringen; Yun Wang; Vanessa Dumeaux; Jahn M Nesland; Gunnar Kristensen; Anne-Lise Borresen-Dale; Anne Dorum
TP53 mutations in ovarian carcinomas from sporadic cases and carriers of two distinct BRCA1 founder mutations; relation to age at diagnosis and survival.
BMC cancer 2005;5():134.
2005: Marci E Schaner; Ben Davidson; Martina Skrede; Reuven Reich; Vivi Ann Flørenes; Björn Risberg; Aasmund Berner; Iris Goldberg; Vered Givant-Horwitz; Claes G Tropè; Gunnar Kristensen; Jahn M Nesland; Anne-Lise Børresen-Dale
Variation in gene expression patterns in effusions and primary tumors from serous ovarian cancer patients.
Molecular cancer 2005;4():26.
2005: Yu-Chi Chen; Gudrun Pohl; Tian-Li Wang; Patrice J Morin; Björn Risberg; Gunnar Kristensen; Albert Yu; Ben Davidson; Ie-Ming Shih
Apolipoprotein E is required for cell proliferation and survival in ovarian cancer.
Cancer research 2005;65(1):331-7.
2004: Gunnar Kristensen; Claes Tropé
Endometrial cancer: the management of high-risk disease.
Current oncology reports 2004;6(6):471-5.
2004: Heidi Lyng; Marzieh Beigi; Debbie H Svendsrud; Odd T Brustugun; Trond Stokke; Gunnar Kristensen; Kolbein Sundfør; Ane Skjønsberg; Paula M de Angelis
Intratumor chromosomal heterogeneity in advanced carcinomas of the uterine cervix.
International journal of cancer. Journal international du cancer 2004;111(3):358-66.
2004: Gregg van de Putte; Gunnar Kristensen; Mark Baekelandt; A Kathrine Lie; Ruth Holm
E-cadherin and catenins in early squamous cervical carcinoma.
Gynecologic oncology 2004;94(2):521-7.
2004: Dianqing Wu; Zhenhe Suo; Gunnar Kristensen; Shanshan Li; Gunhild Troen; Ruth Holm; Jahn M Nesland
Prognostic value of EphA2 and EphrinA-1 in squamous cell cervical carcinoma.
Gynecologic oncology 2004;94(2):312-9.
2004: Yun Wang; Pedro Kringen; Gunnar Kristensen; Ruth Holm; Mark Baekelandt; Magali Olivier; Hanne Skomedal; Pierre Hainaut; Claes G Tropé; Vera M Abeler; Jahn M Nesland; Anne-Lise Børresen-Dale; Aslaug Helland
Effect of the codon 72 polymorphism (c.215G>C, p.Arg72Pro) in combination with somatic sequence variants in the TP53 gene on survival in patients with advanced ovarian carcinoma.
Human mutation 2004;24(1):21-34.
2004: Francesca Micci; Manuel Teixeira; Lisbeth Haugom; Gunnar Kristensen; Vera M Abeler; Sverre Heim
Genomic aberrations in carcinomas of the uterine corpus.
Genes, chromosomes & cancer 2004;40(3):229-46.
2004: Ben Davidson; Emilyn Alejandro; Vivi Ann Flørenes; Jeanne-Mette Goderstad; Björn Risberg; Gunnar Kristensen; Claes G Trope; Elise C Kohn
Granulin-epithelin precursor is a novel prognostic marker in epithelial ovarian carcinoma.
Cancer 2004;100(10):2139-47.
2004: Yun Wang; Aslaug Helland; Ruth Holm; Hanne Skomedal; Vera M Abeler; Håvard E Danielsen; Claes G Tropé; Anne-Lise Børresen-Dale; Gunnar Kristensen
TP53 mutations in early-stage ovarian carcinoma, relation to long-term survival.
British journal of cancer 2004;90(3):678-85.
2004: Dan Wu; Yuhuan Qiao; Gunnar Kristensen; Shanshan Li; Gunhild Troen; Ruth Holm; Jahn M Nesland; Zhenhe Suo
Prognostic significance of dysadherin expression in cervical squamous cell carcinoma.
Pathology oncology research : POR 2004;10(4):212-8.
2004: Ben Davidson; Iris Goldberg; Liora Tell; Sophya Vigdorchik; Mark Baekelandt; Aasmund Berner; Gunnar Kristensen; Reuven Reich; Juri Kopolovic
The clinical role of the PEA3 transcription factor in ovarian and breast carcinoma in effusions.
Clinical & experimental metastasis 2004;21(3):191-9.
2004: Gregg van de Putte; Gunnar Kristensen; A Kathrine Lie; Mark Baekelandt; Ruth Holm
Cyclins and proliferation markers in early squamous cervical carcinoma.
Gynecologic oncology 2004;92(1):40-6.
2003: Gunnar Kristensen; Ignace Vergote; G Stuart; J M Del Campo; Janne Kaern; A B Lopez; Elizabeth Eisenhauer; E Aavall-Lundquist; M Ridderheim; H Havsteen; Mansoor Raza Mirza; M Scheistroen; E Vrdoljak
First-line treatment of ovarian cancer FIGO stages IIb-IV with paclitaxel/epirubicin/carboplatin versus paclitaxel/carboplatin.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2003;13 Suppl 2():172-7.
2003: G Cecilie Alfsen; Wenche Reed; Berit Sandstad; Gunnar Kristensen; Vera M Abeler
The prognostic impact of cyclin dependent kinase inhibitors p21WAF1, p27Kip1, and p16INK4/MTS1 in adenocarcinomas of the uterine cervix: an immunohistochemical evaluation of expression patterns in population-based material from 142 patients with international federation of gynecology and obstetrics stage I and II adenocarcinoma.
Cancer 2003;98(9):1880-9.
2003: Marci E Schaner; Douglas T Ross; Giuseppe Ciaravino; Therese Sorlie; Olga G Troyanskaya; Maximilian Diehn; Yan C Wang; George E Duran; Thomas L Sikic; Sandra Caldeira; Hanne Skomedal; I-Ping Tu; Tina Hernandez-Boussard; Steven W Johnson; Peter J O'Dwyer; Michael Fero; Gunnar Kristensen; Anne-Lise Borresen-Dale; Trevor Hastie; Robert Tibshirani; Matt van de Rijn; Nelson N Teng; Teri A Longacre; David Botstein; Patrick O Brown; Branimir I Sikic
Gene expression patterns in ovarian carcinomas.
Molecular biology of the cell 2003;14(11):4376-86.
2003: Gunnar Kristensen; Wanja Kildal; Vera M Abeler; Janne Kaern; Ignace Vergote; Claes G Tropé; Håvard E Danielsen
Large-scale genomic instability predicts long-term outcome for women with invasive stage I ovarian cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(10):1494-500.
2003: Marianne Kristiansen; Aslaug Helland; Gunnar Kristensen; Anne O Olsen; Per Eystein Lønning; Anne-Lise Børresen-Dale; Karen Helene Ørstavik
X chromosome inactivation in cervical cancer patients.
Cancer genetics and cytogenetics 2003;146(1):73-6.
2003: Wanja Kildal; Sigrid M Kraggerud; Vera M Abeler; Sverre Heim; Claes G Tropé; Gunnar Kristensen; Björn Risberg; Ragnhild A Lothe; Håvard E Danielsen
Genome profiles of bilateral dysgerminomas, a unilateral gonadoblastoma, and a metastasis from a 46, XY phenotypic female.
Human pathology 2003;34(9):946-9.
2003: M K B Parmar; Jonathan A Ledermann; N Colombo; A du Bois; J-F Delaloye; Gunnar Kristensen; S Wheeler; Ann Marie Swart; W Qian; V Torri; Irene Floriani; G Jayson; A Lamont; C Tropé
Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial.
Lancet 2003;361(9375):2099-106.
2003: Gregg van de Putte; Ruth Holm; A Kathrine Lie; Claes G Tropé; Gunnar Kristensen
Expression of p27, p21, and p16 protein in early squamous cervical cancer and its relation to prognosis.
Gynecologic oncology 2003;89(1):140-7.
2003: Vered Givant-Horwitz; Ben Davidson; Gregg van de Putte; Hiep Phuc Dong; Iris Goldberg; Sivan Amir; Gunnar Kristensen; Reuven Reich
Expression of the 67 kDa laminin receptor and the alpha6 integrin subunit in serous ovarian carcinoma.
Clinical & experimental metastasis 2003;20(7):599-609.
2003: Ben Davidson; Iris Goldberg; Aasmund Berner; Gunnar Kristensen; Reuven Reich
EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma.
Clinical & experimental metastasis 2003;20(2):161-9.
2002: Ben Davidson; Iris Goldberg; Vered Givant-Horwitz; Jahn M Nesland; Aasmund Berner; Magne Bryne; Björn Risberg; Juri Kopolovic; Gunnar Kristensen; Claes G Tropé; Gregg van de Putte; Reuven Reich
Caveolin-1 expression in ovarian carcinoma is MDR1 independent.
American journal of clinical pathology 2002;117(2):225-34.
2002: Ben Davidson; Reuven Reich; Juri Kopolovic; Aasmund Berner; Jahn M Nesland; Gunnar Kristensen; Claes G Tropé; Magne Bryne; Björn Risberg; Gregg van de Putte; Iris Goldberg
Interleukin-8 and vascular endothelial growth factor mRNA and protein levels are down-regulated in ovarian carcinoma cells in serous effusions.
Clinical & experimental metastasis 2002;19(2):135-44.
2001: Ben Davidson; Björn Risberg; Iris Goldberg; Jahn M Nesland; Aasmund Berner; Claes G Tropé; Gunnar Kristensen; Magne Bryne; Reuven Reich
Ets-1 mRNA expression in effusions of serous ovarian carcinoma patients is a marker of poor outcome.
The American journal of surgical pathology 2001;25(12):1493-500.
2001: G Cecilie Alfsen; Gunnar Kristensen; E Skovlund; EO Pettersen; Vera M Abeler
Histologic subtype has minor importance for overall survival in patients with adenocarcinoma of the uterine cervix: a population-based study of prognostic factors in 505 patients with nonsquamous cell carcinomas of the cervix.
Cancer 2001;92(9):2471-83.
2001: Ben Davidson; Philip Lazarovici; A Ezersky; Jahn M Nesland; Aasmund Berner; Björn Risberg; Claes G Tropé; Gunnar Kristensen; M Goscinski; Gregg van de Putte; Reuven Reich
Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(11):3457-64.
2001: Ben Davidson; Björn Risberg; Aasmund Berner; Jahn M Nesland; Claes G Tropé; Gunnar Kristensen; Magne Bryne; M Goscinski; Gregg van de Putte; Vivi Ann Flørenes
Expression of cell cycle proteins in ovarian carcinoma cells in serous effusions-biological and prognostic implications.
Gynecologic oncology 2001;83(2):249-56.
2001: Ben Davidson; Reuven Reich; Aasmund Berner; Vered Givant-Horwitz; Iris Goldberg; Björn Risberg; Gunnar Kristensen; Claes G Trope; Magne Bryne; Juri Kopolovic; Jahn M Nesland
Ovarian carcinoma cells in serous effusions show altered MMP-2 and TIMP-2 mRNA levels.
European journal of cancer (Oxford, England : 1990) 2001;37(16):2040-9.
2001: Daniel L Clarke-Pearson; Linda Van Le; T Iveson; CW Whitney; P Hanjani; Gunnar Kristensen; John Malfetano; RA Beckman; GA Ross; SR Lane; Mark DeWitte; Scott Z Fields
Oral topotecan as single-agent second-line chemotherapy in patients with advanced ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(19):3967-75.
2001: Mark Baekelandt; Gustav Lehne; Claes G Tropé; I Szántó; P Pfeiffer; B Gustavssson; Gunnar Kristensen
Phase I/II trial of the multidrug-resistance modulator valspodar combined with cisplatin and doxorubicin in refractory ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(12):2983-93.
2001: Claes Tropé; Gunnar Kristensen; V M Abeler
Clear-cell and papillary serous cancer: treatment options.
Best practice & research. Clinical obstetrics & gynaecology 2001;15(3):433-46.
2001: Ben Davidson; Iris Goldberg; Aasmund Berner; Jahn M Nesland; Vered Givant-Horwitz; Magne Bryne; Björn Risberg; Gunnar Kristensen; Claes G Tropé; Juri Kopolovic; Reuven Reich
Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusions.
American journal of clinical pathology 2001;115(4):517-24.
2001: H Dai; Ruth Holm; Gunnar Kristensen; Vera M Abeler; Anne-Lise Børresen-Dale; Aslaug Helland
Fibroblast growth factor receptor 3 (FGFR3) - analyses of the S249C mutation and protein expression in primary cervical carcinomas.
Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology 2001;23(2):45-9.
2001: Claes Tropé; Gunnar Kristensen; Jelena Kisic; Janne Kaern
Long-term results from a phase II study of paclitaxel combined with doxorubicin in recurrent platinum refractory ovarian cancer.
European journal of gynaecological oncology 2001;22(3):223-7.
2000: Ben Davidson; Aasmund Berner; Jahn M Nesland; Björn Risberg; HS Berner; Claes G Tropè; Gunnar Kristensen; Magne Bryne; V Ann Florenes
E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions.
The Journal of pathology 2000;192(4):460-9.
2000: Mark Baekelandt; Ruth Holm; Jahn M Nesland; Claes G Tropé; Gunnar Kristensen
Expression of apoptosis-related proteins is an independent determinant of patient prognosis in advanced ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(22):3775-81.
2000: Mark Baekelandt; A Jorunn Nesbakken; Gunnar Kristensen; Claes G Tropé; Vera M Abeler
Carcinoma of the fallopian tube.
Cancer 2000;89(10):2076-84.
2000: Aslaug Helland; Sigrid M Kraggerud; Gunnar Kristensen; Ruth Holm; Vera M Abeler; K Huebner; Anne-Lise Borresen-Dale; Ragnhild A Lothe
Primary cervical carcinomas show 2 common regions of deletion at 3P, 1 within the FHIT gene: evaluation of allelic imbalance at FHIT, RB1 and TP53 in relation to survival.
International journal of cancer. Journal international du cancer 2000;88(2):217-22.
2000: I Vergote; G J Rustin; Elizabeth A Eisenhauer; Gunnar Kristensen; Eric Pujade-Lauraine; M K B Parmar; M Friedlander; A Jakobsen; J B Vermorken
Re: new guidelines to evaluate the response to treatment in solid tumors [ovarian cancer]. Gynecologic Cancer Intergroup.
Journal of the National Cancer Institute 2000;92(18):1534-5.
2000: G Cecilie Alfsen; S O Thoresen; Gunnar Kristensen; E Skovlund; Vera M Abeler
Histopathologic subtyping of cervical adenocarcinoma reveals increasing incidence rates of endometrioid tumors in all age groups: a population based study with review of all nonsquamous cervical carcinomas in Norway from 1966 to 1970, 1976 to 1980, and 1986 to 1990.
Cancer 2000;89(6):1291-9.
2000: Ben Davidson; Aasmund Berner; Jahn M Nesland; Björn Risberg; Gunnar Kristensen; Claes G Tropé; Magne Bryne
Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions.
Human pathology 2000;31(9):1081-7.
2000: C G Tropé; Gunnar Kristensen; AP Makar
Surgery for borderline tumor of the ovary.
Seminars in surgical oncology 2000;19(1):69-75.
2000: Leif Aanderud; Einar Thorsen; G Brattebø; M Forland; Gunnar Kristensen
[Hyperbaric oxygen treatment for radiation reactions].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2000;120(9):1020-2.
2000: Claes Tropé; Janne Kaern; T Hogberg; Vera M Abeler; Bjørn Hagen; Gunnar Kristensen; Mathias Onsrud; EO Pettersen; P Rosenberg; R Sandvei; K Sundfor; Ignace Vergote
Randomized study on adjuvant chemotherapy in stage I high-risk ovarian cancer with evaluation of DNA-ploidy as prognostic instrument.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(3):281-8.
2000: Mark Baekelandt; Ruth Holm; Jahn M Nesland; Claes G Tropé; Gunnar Kristensen
P-glycoprotein expression is a marker for chemotherapy resistance and prognosis in advanced ovarian cancer.
Anticancer research 2000;20(2B):1061-7.
2000: Torbjørn Paulsen; C Marth; Janne Kaern; K Nustad; Gunnar Kristensen; Claes Tropé
Effects of paclitaxel on CA-125 serum levels in ovarian cancer patients.
Gynecologic oncology 2000;76(3):326-30.
2000: HS Berner; Ben Davidson; Aasmund Berner; Björn Risberg; Gunnar Kristensen; Claes G Trope; Gregg van de Putte; Jahn M Nesland
Expression of CD44 in effusions of patients diagnosed with serous ovarian carcinoma--diagnostic and prognostic implications.
Clinical & experimental metastasis 2000;18(2):197-202.
1999: Mark Baekelandt; Ruth Holm; Claes G Tropé; Jahn M Nesland; Gunnar Kristensen
The significance of metastasis-related factors cathepsin-D and nm23 in advanced ovarian cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(11):1335-41.
1999: Anne Dørum; Ketil Heimdal; K Løvslett; Gunnar Kristensen; L J Hansen; R Sandvei; A Schiefloe; Bjørn Hagen; Anna Himmelmann; F Jerve; K Shetelig; I Fjaerestad; Claes Tropé; Pål Møller
Prospectively detected cancer in familial breast/ovarian cancer screening.
Acta obstetricia et gynecologica Scandinavica 1999;78(10):906-11.
1999: Mark Baekelandt; Ruth Holm; Claes G Tropé; Jahn M Nesland; Gunnar Kristensen
Lack of independent prognostic significance of p21 and p27 expression in advanced ovarian cancer: an immunohistochemical study.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10):2848-53.
1999: Mark Baekelandt; Gunnar Kristensen; Claes G Tropé; Jahn M Nesland; Ruth Holm
Epidermal growth factor receptor expression has no independent prognostic significance in advanced ovarian cancer.
Anticancer research 1999;19(5C):4469-74.
1999: Gunnar Kristensen; Vera M Abeler; Björn Risberg; C Trop; Magne Bryne
Tumor size, depth of invasion, and grading of the invasive tumor front are the main prognostic factors in early squamous cell cervical carcinoma.
Gynecologic oncology 1999;74(2):245-51.
1999: Mark Baekelandt; Gunnar Kristensen; Jahn M Nesland; Claes G Tropé; Ruth Holm
Clinical significance of apoptosis-related factors p53, Mdm2, and Bcl-2 in advanced ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(7):2061.
1999: Ben Davidson; Björn Risberg; Gunnar Kristensen; Gunnar Kvalheim; Elisabeth Emilsen; A Bjåmer; Aasmund Berner
Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies. Evaluation of five epithelial markers.
Virchows Archiv : an international journal of pathology 1999;435(1):43-9.
1999: Hanne Skomedal; Gunnar Kristensen; A Kathrine Lie; Ruth Holm
Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas.
Gynecologic oncology 1999;73(2):223-8.
1999: Manuel Teixeira; Gunnar Kristensen; Vera M Abeler; Sverre Heim
Karyotypic findings in tumors of the vulva and vagina.
Cancer genetics and cytogenetics 1999;111(1):87-91.
1999: Hanne Skomedal; Aslaug Helland; Gunnar Kristensen; Ruth Holm; Anne-Lise Børresen-Dale
Allelic imbalance at chromosome region 11q23 in cervical carcinomas.
European journal of cancer (Oxford, England : 1990) 1999;35(4):659-63.
1999: Hanne Skomedal; Gunnar Kristensen; Jahn M Nesland; Anne-Lise Børresen-Dale; Claes Tropé; Ruth Holm
TP53 alterations in relation to the cell cycle-associated proteins p21, cyclin D1, CDK4, RB, MDM2, and EGFR in cancers of the uterine corpus.
The Journal of pathology 1999;187(5):556-62.
1998: Magne Bryne; Morten Boysen; C G Alfsen; Vera M Abeler; Jon Sudbø; J M Nesland; Gunnar Kristensen; J Piffko; A Bankfalvi
The invasive front of carcinomas. The most important area for tumour prognosis?
Anticancer research 1998;18(6B):4757-64.
1998: L S Hofstra; Gunnar Kristensen; P H B Willemse; A Vindevoghel; H Meden; M Lahousen; F Oberling; B Sorbe; M Crump; I Sklenar; Wim J Sluiter; B Kiese; Claes G Trope; Elisabeth G E de Vries
Randomized trial of recombinant human interleukin-3 versus placebo in prevention of bone marrow depression during first-line chemotherapy for ovarian carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(10):3335-44.
1998: Wim W ten Bokkel Huinink; C A de Swart; D W van Toorn; G Morack; WP Breed; H F Hillen; J J van der Hoeven; N S Reed; D J Fairlamb; S Y Chan; K A Godfrey; Gunnar Kristensen; H van Tinteren; B Ehmer
Controlled multicentre study of the influence of subcutaneous recombinant human erythropoietin on anaemia and transfusion dependency in patients with ovarian carcinoma treated with platinum-based chemotherapy.
Medical oncology (Northwood, London, England) 1998;15(3):174-82.
1998: C Marth; Claes Tropé; I B Vergote; Gunnar Kristensen
Ten-year results of a randomised trial comparing cisplatin with cisplatin and cyclophosphamide in advanced, suboptimally debulked ovarian cancer.
European journal of cancer (Oxford, England : 1990) 1998;34(8):1175-80.
1998: R R Nordal; Gunnar Kristensen; Anna E Stenwig; Claes G Tropé; J M Nesland
Immunohistochemical analysis of p53 protein in uterine sarcomas.
Gynecologic oncology 1998;70(1):45-8.
1998: Aslaug Helland; Frank Karlsen; E U Due; Ruth Holm; Gunnar Kristensen; Anne-Lise Børresen-Dale
Mutations in the TP53 gene and protein expression of p53, MDM 2 and p21/WAF-1 in primary cervical carcinomas with no or low human papillomavirus load.
British journal of cancer 1998;78(1):69-72.
1998: Mina Kalantari; Frank Karlsen; Gunnar Kristensen; Ruth Holm; Bjorn Hagmar; B Johansson
Disruption of the E1 and E2 reading frames of HPV 16 in cervical carcinoma is associated with poor prognosis.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 1998;17(2):146-53.
1998: Helene Schulerud; Gunnar Kristensen; Knut Liestøl; L Vlatkovic; Albrecht Reith; Fritz Albregtsen; Håvard E Danielsen
A review of caveats in statistical nuclear image analysis.
Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology 1998;16(2):63-82.
1997: R R Nordal; Gunnar Kristensen; A E Stenwig; Jahn M Nesland; E O Pettersen; Claes G Trope
An evaluation of prognostic factors in uterine carcinosarcoma.
Gynecologic oncology 1997;67(3):316-21.
1997: Claes Tropé; Gunnar Kristensen
Current status of chemotherapy in gynecologic cancer.
Seminars in oncology 1997;24(5 Suppl 15):S15-1-S15-22.
1997: Claes Tropé; Janne Kaern; Gunnar Kristensen; P Rosenberg; Bengt Sorbe
Paclitaxel in untreated FIGO stage III suboptimally resected ovarian cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(8):803-6.
1997: Aslaug Helland; Anne-Lise Børresen-Dale; Päivi Peltomäki; Merete Hektoen; Gunnar Kristensen; Jahn M Nesland; ALBERT DE LA CHAPELLE; Ragnhild A Lothe
Microsatellite instability in cervical and endometrial carcinomas.
International journal of cancer. Journal international du cancer 1997;70(5):499-501.
1997: Hanne Skomedal; Gunnar Kristensen; Vera M Abeler; Anne-Lise Børresen-Dale; Claes Tropé; Ruth Holm
TP53 protein accumulation and gene mutation in relation to overexpression of MDM2 protein in ovarian borderline tumours and stage I carcinomas.
The Journal of pathology 1997;181(2):158-65.
1997: Gunnar Kristensen; C Tropé
Epithelial ovarian carcinoma.
Lancet 1997;349(9045):113-7.
1996: Anne Dørum; Gunnar Kristensen; Vera M Abeler; Claes G Tropé; Pål Møller
Early detection of familial ovarian cancer.
European journal of cancer (Oxford, England : 1990) 1996;32A(10):1645-51.
1996: Frank Karlsen; Mina Kalantari; A Jenkins; E Pettersen; Gunnar Kristensen; Ruth Holm; B Johansson; Bjorn Hagmar
Use of multiple PCR primer sets for optimal detection of human papillomavirus.
Journal of clinical microbiology 1996;34(9):2095-100.
1996: R R Nordal; Gunnar Kristensen; Janne Kaern; Anna E Stenwig; E O Pettersen; Claes G Tropé
The prognostic significance of surgery, tumor size, malignancy grade, menopausal status, and DNA ploidy in endometrial stromal sarcoma.
Gynecologic oncology 1996;62(2):254-9.
1996: Gunnar Kristensen; Ruth Holm; Vera M Abeler; Claes G Tropé
Evaluation of the prognostic significance of cathepsin D, epidermal growth factor receptor, and c-erbB-2 in early cervical squamous cell carcinoma. An immunohistochemical study.
Cancer 1996;78(3):433-40.
1996: Gunnar Kristensen; Frank Karlsen; A Jenkins; Janne Kaern; Vera M Abeler; Claes G Tropé
Human papilloma virus has no prognostic significance in cervical carcinoma.
European journal of cancer (Oxford, England : 1990) 1996;32A(8):1349-53.
1996: Gunnar Kristensen; Ruth Holm; Vera M Abeler; Claes G Tropé
Evaluation of the prognostic significance of nm23/NDP kinase protein expression in cervical carcinoma: an immunohistochemical study.
Gynecologic oncology 1996;61(3):378-83.
1996: Marit Scheistrøen; Claes Tropé; Janne Kaern; Vera M Abeler; E O Pettersen; Gunnar Kristensen
Malignant melanoma of the vulva FIGO stage I: Evaluation of prognostic factors in 43 patients with emphasis on DNA ploidy and surgical treatment.
Gynecologic oncology 1996;61(2):253-8.
1996: Janne Kaern; Claes Tropé; K Sundfoer; Gunnar Kristensen
Cisplatin/5-fluorouracil treatment of recurrent cervical carcinoma: a phase II study with long-term follow-up.
Gynecologic oncology 1996;60(3):387-92.
1995: Hanne Skomedal; Gunnar Kristensen; Ruth Holm
Expression of retinoblastoma tumor suppressor gene protein, epidermal growth factor receptor, and c-erbB-2 oncoprotein in primary vaginal carcinomas.
Gynecologic oncology 1995;59(3):379-83.
1995: Gunnar Kristensen; Mark Baekelandt; I B Vergote; Claes Tropé
A phase II study of carboplatin and hexamethylmelamine as induction chemotherapy in advanced epithelial ovarian carcinoma.
European journal of cancer (Oxford, England : 1990) 1995;31A(11):1778-80.
1995: Hanne Skomedal; Gunnar Kristensen; Aslaug Helland; Jahn M Nesland; S Kooi; A L Børresen; Ruth Holm
TP53 gene mutations and protein accumulation in primary vaginal carcinomas.
British journal of cancer 1995;72(1):129-33.
1995: Gunnar Kristensen; Janne Kaern; Vera M Abeler; B Hagmar; Claes G Tropé; E O Pettersen
No prognostic impact of flow-cytometric measured DNA ploidy and S-phase fraction in cancer of the uterine cervix: a prospective study of 465 patients.
Gynecologic oncology 1995;57(1):79-85.
1995: C Tropé; Gunnar Kristensen
[Preoperative identification of malignancy among women with a pelvic mass].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1995;115(7):812-3.
1995: A P Makar; Mark Baekelandt; Claes G Tropé; Gunnar Kristensen
The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer.
Gynecologic oncology 1995;56(2):175-80.
1995: Marit Scheistrøen; Claes Tropé; J Koern; E O Pettersen; Vera M Abeler; Gunnar Kristensen
Malignant melanoma of the vulva. Evaluation of prognostic factors with emphasis on DNA ploidy in 75 patients.
Cancer 1995;75(1):72-80.
1995: Frank Karlsen; Gunnar Kristensen; Ruth Holm; M Chitemerere; Aasmund Berner; Bjorn Hagmar
High incidence of human papillomavirus in 146 cervical carcinomas. A study using three different pairs of consensus primers, and detecting viral genomes with putative deletions.
European journal of cancer (Oxford, England : 1990) 1995;31A(9):1511-6.
1995: R R Nordal; Gunnar Kristensen; Janne Kaern; Anna E Stenwig; E O Pettersen; Claes G Tropé
The prognostic significance of stage, tumor size, cellular atypia and DNA ploidy in uterine leiomyosarcoma.
Acta oncologica (Stockholm, Sweden) 1995;34(6):797-802.
1994: Aslaug Helland; A L Børresen; Gunnar Kristensen; Kjersti S Rønningen
DQA1 and DQB1 genes in patients with squamous cell carcinoma of the cervix: relationship to human papillomavirus infection and prognosis.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1994;3(6):479-86.
1994: Janne Kaern; Claes G Tropé; Gunnar Kristensen; E O Pettersen
Flow cytometric DNA ploidy and S-phase heterogeneity in advanced ovarian carcinoma.
Cancer 1994;73(7):1870-7.
1994: E Kristiansen; A Jenkins; Gunnar Kristensen; E Ask; Janne Kaern; V Abeler; B H Lindqvist; C Tropé; B E Kristiansen
Human papillomavirus infection in Norwegian women with cervical cancer.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 1994;102(2):122-8.
1994: Janne Kaern; Claes G Tropé; Gunnar Kristensen; Kjell Magne Tveit; E O Pettersen
Evaluation of deoxyribonucleic acid ploidy and S-phase fraction as prognostic parameters in advanced epithelial ovarian carcinoma: a prospective study.
American journal of obstetrics and gynecology 1994;170(2):479-87.
1994: Anne Dørum; Gunnar Kristensen; Claes Tropé
A randomised study of cisplatin versus thiotepa as induction chemotherapy in advanced ovarian carcinoma.
European journal of cancer (Oxford, England : 1990) 1994;30A(10):1470-4.
1993: Claes Tropé; Janne Kaern; I B Vergote; Gunnar Kristensen; Vera M Abeler
Are borderline tumors of the ovary overtreated both surgically and systemically? A review of four prospective randomized trials including 253 patients with borderline tumors.
Gynecologic oncology 1993;51(2):236-43.
1993: Aslaug Helland; Ruth Holm; Gunnar Kristensen; Janne Kaern; Frank Karlsen; C Trope; Jahn M Nesland; A L Børresen
Genetic alterations of the TP53 gene, p53 protein expression and HPV infection in primary cervical carcinomas.
The Journal of pathology 1993;171(2):105-14.
1993: A P Makar; Gunnar Kristensen; Ole P Børmer; Claes G Tropé
Serum CA 125 level allows early identification of nonresponders during induction chemotherapy.
Gynecologic oncology 1993;49(1):73-9.
1993: A P Makar; Gunnar Kristensen; Ole P Børmer; Claes G Tropé
Is serum CA 125 at the time of relapse a prognostic indicator for further survival prognosis in patients with ovarian cancer?
Gynecologic oncology 1993;49(1):3-7.
1993: Anne Dørum; Gunnar Kristensen; A Langebrekke; T Sørnes; O Skaar
Evaluation of endometrial thickness measured by endovaginal ultrasound in women with postmenopausal bleeding.
Acta obstetricia et gynecologica Scandinavica 1993;72(2):116-9.
1993: Ruth Holm; Hanne Skomedal; Aslaug Helland; Gunnar Kristensen; A L Børresen; Jahn M Nesland
Immunohistochemical analysis of p53 protein overexpression in normal, premalignant, and malignant tissues of the cervix uteri.
The Journal of pathology 1993;169(1):21-6.
1992: A P Makar; Gunnar Kristensen; Ole P Børmer; Claes G Tropé
CA 125 measured before second-look laparotomy is an independent prognostic factor for survival in patients with epithelial ovarian cancer.
Gynecologic oncology 1992;45(3):323-8.
1992: A P Makar; Gunnar Kristensen; Janne Kaern; Ole P Børmer; Vera M Abeler; Claes G Tropé
Prognostic value of pre- and postoperative serum CA 125 levels in ovarian cancer: new aspects and multivariate analysis.
Obstetrics and gynecology 1992;79(6):1002-10.
1991: Gunnar Kristensen; K D Skyggebjerg; Berit Hølund; K Holm; M K Hansen
Analysis of cervical smears obtained within three years of the diagnosis of invasive cervical cancer.
Acta cytologica 1991;35(1):47-50.
1990: Gunnar Kristensen; L K Jensen; Berit Hølund
A randomized trial comparing two methods of cold knife conization with laser conization.
Obstetrics and gynecology 1990;76(6):1009-13.
1990: Gunnar Kristensen; E C Beiter; O Mather
Single-dose cefuroxime prophylaxis in non-elective cesarean section.
Acta obstetricia et gynecologica Scandinavica 1990;69(6):497-500.
1989: Gunnar Kristensen; Berit Hølund; Per Grinsted
Efficacy of the cytobrush versus the cotton swab in the collection of endocervical cells.
Acta cytologica 1989;33(6):849-51.
1989: Gunnar Kristensen; L K Jensen; Dorthe Ejersbo; Berit Hølund
The efficiency of the cytobrush and cotton swab in obtaining endocervical cells in smears taken after conization of the cervix.
Archives of gynecology and obstetrics 1989;246(4):207-10.
1988: Anders Jakobsen; P Bichel; Gunnar Kristensen; M Nyland
Prognostic influence of ploidy level and histopathologic differentiation in cervical carcinoma stage Ib.
European journal of cancer & clinical oncology 1988;24(6):969-72.
1987: K Lind; Gunnar Kristensen
Significance of antibodies to Mycoplasma genitalium in salpingitis.
European journal of clinical microbiology 1987;6(2):205-7.
1985: K Lind; Gunnar Kristensen; A C Bollerup; P Ladehoff; S Larsen; A Marushak; P Rasmussen; J Rolschau; I Skoven; T Sørensen
Importance of Mycoplasma hominis in acute salpingitis assessed by culture and serological tests.
Genitourinary medicine 1985;61(3):185-9.
1985: Gunnar Kristensen; A C Bollerup; K Lind; P A Mårdh; P Ladehoff; S Larsen; A Marushak; P Rasmussen; J Rolschau; I Skoven
Infections with Neisseria gonorrhoeae and Chlamydia trachomatis in women with acute salpingitis.
Genitourinary medicine 1985;61(3):179-84.
1985: Gunnar Kristensen
The outcome of pregnancy and preterm delivery after conization of the cervix.
Archives of gynecology 1985;236(3):127-30.
1984: O Mather; Gunnar Kristensen; H K Jensen
[Prenatal evaluation of fetal lung maturity by measuring the optical density of amniotic fluid].
Ugeskrift for laeger 1984;146(47):3635-7.
1984: Gunnar Kristensen
[Safety belts and fetal fractures of the cranium].
Ugeskrift for laeger 1984;146(46):3553-4.
1984: E Andreasen; Gunnar Kristensen; G T Pedersen; D Stahl
[Evaluation of disposable and re-usable scalp electrodes].
Ugeskrift for laeger 1984;146(41):3124-6.
1984: Gunnar Kristensen; P Baunsgaard; H Hesseldahl
Androblastoma associated with pregnancy in two sisters. Case report.
British journal of obstetrics and gynaecology 1984;91(6):592-5.
1984: Gunnar Kristensen; P C Frimodt-Møller; H K Poulsen; S Ulbak
Persistent bladder dysfunction after surgical and combination therapy of cancer of the cervix uteri stages Ib and IIa.
Gynecologic oncology 1984;18(1):38-42.
1983: N Foged; Gunnar Kristensen; J Kamper
[Transcutaneous bilirubinometry. A non-invasive method of measuring physiological jaundice].
Ugeskrift for laeger 1983;145(38):2935-7.
1983: Gunnar Kristensen; J Hariri; E Diernaes
[Arrhenoblastomata in both ovaries with a 2-year interval].
Ugeskrift for laeger 1983;145(5):331-2.
1983: H K Poulsen; Gunnar Kristensen; M K Hansen
[Sexual dysfunction following operation for cancer of the uterine cervix stages Ib and IIa].
Ugeskrift for laeger 1983;145(3):162-4.
1981: Gunnar Kristensen; K Hansen
[Cryocoagulation therapy of intra-epithelial cervical neoplasm].
Ugeskrift for laeger 1981;143(41):2639-41.
1980: Gunnar Kristensen
[2 cases of injuries caused by safety belts in pregnant women].
Ugeskrift for laeger 1980;142(17):1092-3.